Literature DB >> 2507926

The alpha-lytic protease pro-region does not require a physical linkage to activate the protease domain in vivo.

J L Silen1, D A Agard.   

Abstract

alpha-Lytic protease, an extracellular serine protease of Lysobacter enzymogenes 495, is synthesized as a pre-pro-protein. Previously it has been shown that when expressed in Escherichia coli, the protein is autocatalytically processed in the periplasmic space, and that the functional protease domain accumulates extracellularly. Engineered proteins lacking the 166 amino-acid pro-region were enzymatically inactive and remained cell-associated. By independently expressing the pro- and protease domains in vivo, evidence is provided here that direct covalent linkage is not required for production of active protease. We postulate that the pro-region acts as a template to promote the folding of the protease domain into an active configuration. Our results, combined with recent experiments on the evolutionarily unrelated subtilisin E (ref. 3), suggest that the ability of the pro-region of these bacterial proteases to facilitate folding of their protease domains is not a curiosity of a single system, but may reflect a general property of extracellular bacterial serine proteases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507926     DOI: 10.1038/341462a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  49 in total

1.  Kinetic stability as a mechanism for protease longevity.

Authors:  E L Cunningham; S S Jaswal; J L Sohl; D A Agard
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  The Kex2p proregion is essential for the biosynthesis of an active enzyme and requires a C-terminal basic residue for its function.

Authors:  G Lesage; A Prat; J Lacombe; D Y Thomas; N G Seidah; G Boileau
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

3.  Novel mechanisms control the folding and assembly of lambda5/14.1 and VpreB to produce an intact surrogate light chain.

Authors:  Y Minegishi; L M Hendershot; M E Conley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  pH-induced conformational transitions of a molten-globule-like state of the inhibitory prodomain of furin: implications for zymogen activation.

Authors:  S Bhattacharjya; P Xu; H Xiang; M Chrétien; N G Seidah; F Ni
Journal:  Protein Sci       Date:  2001-05       Impact factor: 6.725

5.  Disabling the folding catalyst is the last critical step in alpha-lytic protease folding.

Authors:  Erin L Cunningham; David A Agard
Journal:  Protein Sci       Date:  2004-02       Impact factor: 6.725

6.  Ca2+-dependent maturation of subtilisin from a hyperthermophilic archaeon, Thermococcus kodakaraensis: the propeptide is a potent inhibitor of the mature domain but is not required for its folding.

Authors:  Marian Pulido; Kenji Saito; Shun-Ichi Tanaka; Yuichi Koga; Masaaki Morikawa; Kazufumi Takano; Shigenori Kanaya
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

7.  Regulation of transcription factor latency by receptor-activated proteolysis.

Authors:  Claes Andréasson; Stijn Heessen; Per O Ljungdahl
Journal:  Genes Dev       Date:  2006-06-15       Impact factor: 11.361

8.  Crystallization and preliminary X-ray diffraction study of an active-site mutant of pro-Tk-subtilisin from a hyperthermophilic archaeon.

Authors:  Shun-ichi Tanaka; Kenji Saito; Hyongi Chon; Hiroyoshi Matsumura; Yuichi Koga; Kazufumi Takano; Shigenori Kanaya
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-18

9.  Differences in the autocatalytic cleavage of pro-PC2 and pro-PC3 can be attributed to sequences within the propeptide and Asp310 of pro-PC2.

Authors:  K Scougall; N A Taylor; J L Jermany; K Docherty; K I Shennan
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

10.  Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins.

Authors:  C Failla; L Tomei; R De Francesco
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.